The table below shows RHYTHM PHARMACEUTICALS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$189.76M
$130.13M
$77.43M
$23.64M
$3.15M
$0.00
Cost of revenue
$19.49M
$13.37M
$9.30M
$2.13M
$599.00K
-
Gross profit
-
-
-
-
-
-
R&D
$167.34M
$237.96M
$134.95M
$108.63M
$104.13M
$90.45M
SG&A
RYTM annual revenue (10-K history)
RHYTHM PHARMACEUTICALS, INC. reported annual revenue of $189.76M for fiscal year 2025. That is up 45.8% from $130.13M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
